NC
ARKG icon

NewSquare Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

NewSquare Capital’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25
Closed -$653 – 916
2024
Q3 		$653 Buy
+25
New +$637 ﹤0.01% 283
2024
Q2 		– Hold
0
– – – 345
2023
Q3 		– Sell
-45
Closed -$1.53K – 615
2023
Q2 		$1.53K Buy
45
+35
+350% +$1.1K ﹤0.01% 558
2023
Q1 		$301 Hold
10
– – ﹤0.01% 760
2022
Q4 		$282 Buy
+10
New +$317 ﹤0.01% 706

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NewSquare Capital's ARKG Position: Q4 2024 in Review

NewSquare Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 25 shares — an estimated $653 sold.

NewSquare Capital first reported a position in ARKG in Q4 2022 and held it in 4 quarters. The position peaked at $1.53K in Q2 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • NewSquare Capital reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • NewSquare Capital sold 25 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $653.
  • NewSquare Capital first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 4 quarters.
  • NewSquare Capital's ARK Genomic Revolution ETF position peaked at $1.53K in Q2 2023.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on NewSquare Capital's 13F filing for Q4 2024, filed 6 Feb 2025.